基于人工智能的胃癌精准诊疗研究进展：从辅助诊断到预后预测

Advances in artificial intelligence-based precision diagnosis and treatment of gastric cancer: from auxiliary diagnosis to prognosis

摘要

作为发病率较高的恶性肿瘤，胃癌的早期诊断与精准治疗始终是临床难点。基于机器学习与深度学习的人工智能，正在重塑胃癌“诊-治-管”全周期模式。在诊断方面，人工智能提升内镜、病理图像分析效率，助力早期胃癌识别；在治疗中，用于预测治疗反应和辅助新药研发；在预后预测上，构建精准生存期和复发风险预测模型。本文聚焦人工智能在胃癌诊疗领域的创新应用，总结人工智能在胃癌领域中的作用，为推动人工智能与胃癌临床实践的深度融合提供了新思路。

Abstract

Gastric cancer is a malignant tumor with a high incidence rate, and its early diagnosis and precision therapy remain significant clinical challenges. Artificial intelligence based on machine learning and deep learning is reshaping the full-cycle model of "diagnosis-treatment-management" in gastric cancer. In diagnostics, artificial intelligence enhances the efficiency of endoscopy and pathological image analysis, facilitating early detection. In treatment, it predicts therapeutic responses and aids in new drug development. For prognosis, artificial intelligence constructs precise models for survival prediction and recurrence risk assessment. This article focused on the innovative applications of artificial intelligence in gastric cancer diagnosis and treatment, summarized the role of artificial intelligence in the field of gastric cancer, and provided novel insights for promoting the deep integration of artificial intelligence into clinical practice.

关键词

胃癌诊断 / 胃癌治疗 / 人工智能 / 预后预测 / 精准医疗

Key words

gastric cancer diagnosis / gastric cancer treatment / artificial intelligence / prognostic prediction / precision medicine

参考文献

[1] BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. Ca: a cancer journal for clinicians, 2024, 74(3): 229-263.

[2] 郑荣寿, 张思维, 孙可欣, 等. 2016年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2023, 3(1): 212-220.

[3] TOPOL E J. High—performance medicine: the convergence of human and artificial intelligence[J]. Nature medicine, 2019, 25(1): 44-56.

[4] 兰欣, 卫荣, 蔡宏伟, 等. 机器学习算法在医疗领域中的应用[J]. 医疗卫生装备, 2019, 40(3): 5.

[5] LITJENS G, KOOI T, BEJNORDI B E, et al. A survey on deep learning in medical image analysis[J]. Medical image analysis, 2017, 42(13): 60-88.

[6] SUZUKI H, ODA I, ABE S, et al. High rate of 5—year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection[J]. Gastric cancer, 2016, 19(1): 198-205.

[7] SALATI M, DI EMIDIO K, TARANTINO V, et al. Second—line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?[J]. ESMO open, 2017, 2(3): e000206.

[8] WANG Z H, ZHOU X R, LIU W H. Inner countertraction facilitating endoscopic submucosal dissection of a difficult early gastric cancer independent of transparent cap[J]. Endoscopy, 2023, 55(S1): E490-E491.

[9] GAO Y H, WEN P Z, LIU Y, et al. Application of artificial intelligence in the diagnosis of malignant digestive tract tumors: focusing on opportunities and challenges in endoscopy and pathology[J]. Journal of translational medicine, 2025, 23(1): 412.

[10] LI N, YANG J, LI X D, et al. Accuracy of artificial intelligence—assisted endoscopy in the diagnosis of gastric intestinal Metaplasia: a systematic review and meta—analysis[J]. PLoS One, 2024, 19(5): e0303421.

[11] YAO K S, UEDO N, KAMADA T, et al. Guidelines for endoscopic diagnosis of early gastric cancer[J]. Digestive endoscopy, 2020, 32(5): 663-698.

[12] 邹文斌, 杨帆, 李兆申. 中国胃癌诊治关键在于提高早期诊断率[J]. 浙江大学学报: 医学版, 2015(1): 9-14.

[13] WU L L, WANG J, HE X Q, et al. Deep learning system compared with expert endoscopists in predicting early gastric cancer and its invasion depth and differentiation status (with videos)[J]. Gastrointestinal endoscopy, 2022, 95(1): 92-104.e3.

[14] WU L L, ZHOU W, WAN X Y, et al. A deep neural network improves endoscopic detection of early gastric cancer without blind spots[J]. Endoscopy, 2019, 51(6): 522-531.

[15] LI S W, ZHANG L H, CAI Y, et al. Deep learning assists detection of esophageal cancer and precursor lesions in a prospective, randomized controlled study[J]. Science translational medicine, 2024, 16(743): eadk5395.

[16] HIRASAWA T, AOYAMA K, TANIMOTO T, et al. Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images[J]. Gastric cancer, 2018, 21(4): 653-660.

[17] YANG R X, ZHANG J L, ZHAN F S, et al. Artificial intelligence efficiently predicts gastric lesions, Helicobacter pylori infection and lymph node metastasis upon endoscopic images[J]. Chinese journal of cancer research, 2024, 36(5): 489-502.

[18] WANG X Y, ZHAO J H, MAROSTICA E, et al. A pathology foundation model for cancer diagnosis and prognosis prediction[J]. Nature, 2024, 634(8035): 970-978.

[19] SONG Z G, ZOU S M, ZHOU W X, et al. Clinically applicable histopathological diagnosis system for gastric cancer detection using deep learning[J]. Nature communications, 2020, 11(1): 4294.

[20] IWAYA M, HAYASHI Y, SAKAI Y, et al. Artificial intelligence for evaluating the risk of gastric cancer: reliable detection and scoring of intestinal Metaplasia with deep learning algorithms[J]. Gastrointestinal endoscopy, 2023, 98(6): 925-933.e1.

[21] CHEN Y Z, WANG B H, ZHAO Y Z, et al. Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer[J]. Nature communications, 2024, 15(1): 1657.

[22] DING P A, WU H T, WU J X, et al. Non—invasive liquid biopsy based on transcriptomic profiling for early diagnosis of occult peritoneal metastases in locally advanced gastric cancer[J]. NPJ precision oncology, 2025, 9(1): 109.

[23] LEE I S, AHN J, KIM K, et al. A blood—based transcriptomic signature for noninvasive diagnosis of gastric cancer[J]. British journal of cancer, 2021, 125(6): 846-853.

[24] CHEN Z F, CHEN Y, SUN Y, et al. Predicting gastric cancer response to anti—HER2 therapy or anti—HER2 combined immunotherapy based on multi—modal data[J]. Signal transduction and targeted therapy, 2024, 9(1): 222.

[25] HE M, CHEN Z F, LIU S, et al. Deep learning model based on multi—lesion and time series CT images for predicting the benefits from anti—HER2 targeted therapy in stage Ⅳ gastric cancer[J]. Insights into imaging, 2024, 15(1): 59.

[26] 韩枫, 王燕燕, 杜妍, 等. 基于CT影像组学的机器学习模型预测局部进展期胃癌新辅助化疗效果[J]. 肿瘤研究与临床, 2025, 37(1): 1-7.

[27] SASAGAWA S, HONMA Y, PENG X X, et al. Predicting chemotherapy responsiveness in gastric cancer through machine learning analysis of genome, immune, and neutrophil signatures[J]. Gastric cancer, 2025, 28(2): 228-244.

[28] SUNDAR R, BARR KUMARAKULASINGHE N, HUAK CHAN Y, et al. Machine—learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase Ⅲ SAMIT trial[J]. Gut, 2022, 71(4): 676-685.

[29] LIU Y F, CHEN W, RUAN R W, et al. Deep learning based digital pathology for predicting treatment response to first—line PD—1 blockade in advanced gastric cancer[J]. Journal of translational medicine, 2024, 22(1): 438.

[30] HUANG W C, WANG X Y, ZHONG R, et al. Multimodal radiopathomics signature for prediction of response to immunotherapy—based combination therapy in gastric cancer using interpretable machine learning[J]. Cancer letters, 2025, 631: 217930.

[31] ZHOU Y R, DAI Q H, XU Y M, et al. PharmaFormer predicts clinical drug responses through transfer learning guided by patient derived organoid[J]. NPJ precision oncology, 2025, 9(1): 282.

[32] JUMPER J, EVANS R, PRITZEL A, et al. Highly accurate protein structure prediction with AlphaFold[J]. Nature, 2021, 596(7873): 583-589.

[33] WU K H, LI X, ZHOU Z, et al. Predicting pharmacodynamic effects through early drug discovery with artificial intelligence—physiologically based pharmacokinetic (AI—PBPK) modelling[J]. Frontiers in pharmacology, 2024, 15: 1330855.

[34] ASHBURN T T, THOR K B. Drug repositioning: identifying and developing new uses for existing drugs[J]. Nature reviews drug discovery, 2004, 3(8): 673-683.

[35] KıRBOĞA K K, RUDRAPAL M. Feature engineering—assisted drug repurposing on disease—drug transcriptome profiles in gastric cancer[J]. ASSAY and drug development technologies, 2024, 22(4): 181-191.

[36] RABBEN H L, ANDERSEN G T, IANEVSKI A, et al. Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer[J]. Frontiers in pharmacology, 2021, 12: 625991.

[37] ZENG J J, LI K, CAO F Y, et al. Development and validation of survival prediction model for gastric adenocarcinoma patients using deep learning: a SEER—based study[J]. Frontiers in oncology, 2023, 13: 1131859.

[38] CHEN Q Y, JIAN L, XIAO H, et al. Transformer—based skeletal muscle deep—learning model for survival prediction in gastric cancer patients after curative resection[J]. Gastric cancer, 2025, 28(4): 684-695.

[39] ZHOU Z X, JIANG Y M, SUN Z P, et al. Virtual multiplexed immunofluorescence staining from non—antibody—stained fluorescence imaging for gastric cancer prognosis[J]. eBioMedicine, 2024, 107: 105287.

[40] VELDHUIZEN G P, RÖCKEN C, BEHRENS H M, et al. Deep learning—based subtyping of gastric cancer histology predicts clinical outcome: a multi—institutional retrospective study[J]. Gastric cancer, 2023, 26(5): 708-720.

[41] LI C, QIN Y, ZHANG W H, et al. Deep learning—based AI model for signet—ring cell carcinoma diagnosis and chemotherapy response prediction in gastric cancer[J]. Medical physics, 2022, 49(3): 1535-1546.

[42] CHEN T, WU J, CUI C H, et al. CT—based radiomics nomograms for preoperative prediction of diffuse—type and signet ring cell gastric cancer: a multicenter development and validation cohort[J]. Journal of translational medicine, 2022, 20(1): 38.

[43] JIANG Y M, ZHANG Z C, YUAN Q Y, et al. Predicting peritoneal recurrence and disease—free survival from CT images in gastric cancer with multitask deep learning: a retrospective study[J]. The lancet digital health, 2022, 4(5): e340-e350.

[44] ZHU Z N, FENG Q X, LI Q, et al. Machine learning—based CT radiomics approach for predicting occult peritoneal metastasis in advanced gastric cancer preoperatively[J]. Clinical radiology, 2025, 80: 106727.

[45] DONG Z H, TAO X, DU H L, et al. Exploring the challenge of early gastric cancer diagnostic AI system face in multiple centers and its potential solutions[J]. Journal of gastroenterology, 2023, 58(10): 978-989.

[46] NASIR M, SIDDIQUI K, AHMED S. Ethical—legal implications of AI—powered healthcare in critical perspective[J]. Frontiers in artificial intelligence, 2025, 8: 1619463.

[47] NA L Y, YANG C, LO C C, et al. Feasibility of reidentifying individuals in large national physical activity data sets from which protected health information has been removed with use of machine learning[J]. JAMA network open, 2018, 1(8): e186040.

[48] WANG S X, WANG S L, WANG Z X. A survey on multi—omics—based cancer diagnosis using machine learning with the potential application in gastrointestinal cancer[J]. Frontiers in medicine, 2023, 9: 1109365.

[49] WANG H C, FU T F, DU Y Q, et al. Scientific discovery in the age of artificial intelligence[J]. Nature, 2023, 620(7972): 47-60.

基金资助

甘肃省科技计划资助项目(21JR7RA433)

甘肃省科技计划资助项目(24YFFA045)